60 Views | 22 Downloads
Stamatina Iliodromiti, Email: s.iliodromiti@qmul.ac.uk
SI, JMcL, JMRG, NS and MAL conceived the idea, SI and JMcL conducted the systematic search, and SI performed the statistical analysis and wrote the first draft. NG and SI conducted the primary studies that provided the unpublished MRI and liver spectroscopy data. SB, JP, JF and SH performed the fat measurements using the primary magnetic resonance images and liver spectroscopy data from the unpublished studies. MRM, ODL and JL measured the fat in MRI images from the UK Biobank data. UPG and AK collected data for the largest primary study included in the meta-analysis. All authors edited and critically assessed the final version of the paper, and gave final approval of the version to be published. JMRG is responsible for the integrity of this work as a whole.
The imaging data from the UK Biobank Resource were provided under application 6569. We thank the UK Biobank participants and coordinators for this unique dataset. The authors thank L. Coyle, University of Glasgow, for her assistance with manuscript preparation.
MRM is employed by and has shareholdings in Pfizer Inc. ODL is employed by and has shareholdings in AMRA Medical AB. JL is employed by AMRA Medical AB. NS reports personal fees from Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer and Sanofi; and grant funding paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis and Roche Diagnostics outside the submitted work. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
There was no primary direct funding for undertaking the systematic review and meta-analysis and authors of the study were supported by their affiliated organisations/institutions during the conduct of the research
The study was partially supported by funding from the European Federation of Pharmaceutical Industries Associations (EFPIA)-Innovative Medicines Initiative (IMI) Joint Undertaking-European Medical Information Framework (EMIF) (grant no. 115372).
SI is funded by a Medical Research Council postdoctoral fellowship (MR/N015177/1). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
© The Author(s) 2022